KC Neuro Flashcards
(246 cards)
Describe the results of the ULTRA trial (TXA in SAH)
Population: Adults with signs and symptoms <24 hours indicating SAH confirmed on non contrast CT. Excluded traumatic SAH, ongoing treatment for VTE.
Intervention: 1G TXA bolus, repeated q8H
Control: Standard of care.
Outcome: Primary outcome 6 month clinical outcome using modified Rankin; ‘good’ mRS 0-3 and ‘poor’ 4-6. No difference in primary or secondary outcomes (excellent clinical outcome, mortality at 1 mo or 60 mo).
Double blind open label RCT with ~1000 pt
Describe the results of the POINT trial
Does the combination of asa + clopidogrel compared to ASA alone reduce the risk of stroke
Population: adult paints with minor stroke NIHSS <4 or TIA with ABCD2 >3. Head CT or MRI. Excluded patients with isolated numbness or dizziness, those who received thrombolytics or EVT
Intervention: 600mg clopidogrel + 75 daily + ASA
Control: placebo + ASA
Outcome: composite major ischemic events (stroke, MI, or death) with primary safety outcome of major hemorrhage. Lower rate of major ischemic events in DAPT and a increased risk of major hemorrhage (but due to non intracranial events). Trial stopped early due to higher risk of hemorrhage in DAPT.
5000+ randomized double blinded trial
DAPT reduces the risk of stroke in 3 months.
Describe the results of the DEFUSE trial
Bottom line: EVT at 6-16 hours improved functional neurological outcomes at 90 days compared with medical therapy alone
Population: 182 patients randomized, 38 hospitals in the US. Included if age 18-90, NIHSS 6+, baseline mRS 0-1, presenting 6-16 hours, + imaging: ICA or MCA with large mismatch
Intervention: thrombectomy + medical therapy
Control: medical therapy (ASA)
Outcome: modified Rankin scale. Median mRs at 90 days: 3 (IQR 1-4) vs. 4 (IQR 3-6).Functional independence (Modified Rankin 0-2) at 90 days – significantly increased with endovascular therapy.45% vs 17%, OR 2.67 (95% C.I. 1.6-4.48), p<0.001.Serious adverse events – no significant difference.
Describe the results of the DAWN trial
In patients 6-24 post stroke with a mismatch between clinical sx and infarct does thrombectomy improve care?
Population: >18 with ischemic stroke, failed IV tPA or contraindication for tPA, last seen normal 6-24 hours ago, baseline mRS 0-1, Ct occlusion ICA or M1, mismatch between severity of symptoms and infarct volume. Exclusion criteria included recent severe head trauma or bleeding, prior thrombectomy, seizure at stroke onset, sustained HTN SBP>185, infarct volume >1/3 MCA territory
Intervention: mechanical thrombectomy with the Trevo device plus standard medical therapy
Control: standard medical therapy alone
Outcome: modified Rankin scale and functional independence at 90d. Secondary outcomes include early therapeutic response, vessel recanalization at 24 hours, change in baseline infarct volume, safety outcomes.
Multicentre RCT 26 centres, unblinded open label
NNT 3 for functional independence for thrombectomy
Overall: Benefit of thrombectomy. Strict inclusion/exclusion criteria with small sample size.
*6 causes of spontaneous cerebral bleed
Hypertensive vasculopathy
Cerebral amyloid angiopathy
Vascular malformations
Drug intox
Malignant hypertension
Saccular aneurysms
Blood dyscrasias
Venous sinus thrombosis
Hemorrhagic transformation
Moya moya
Tumours
*Biggest risk factor for spontaneous bleed
Hypertension
*5 steps in management
IV access and cardiac monitoring
Admission to ICU or specialized unit
Rapid neuroimaging
Airway management
BP target
Reversal ACO
Lower ICP
Consult neuroSx
Treat hyperthermia and hypoglycemia
*Three clinical findings of ACA stroke
Contralateral weakness (legs>arms) and sensory loss
Impaired judgement/insight
Bowel/bladder incontinence
Apraxia/gait clumsiness
*Three clinical findings of PCA stroke
-Contralateral homonymous hemi-anopia
-Alexia without agraphia (cant read but you can write)
-Acalculia (cant process numbers or preform calculations)
-Memory deficit
-Contralateral sensory loss without motor
-Visual agnosia
*Three clinical findings of PICA stroke
-Ipsilateral cerebellar signs (ataxia, dysmetria)
-Ipsilateral Horner syndrome
-Ipsilateral paralysis of palate/laryngeal/pharyngeal muscles
-Loss of pain/T to contralateral body + ipsilateral face
N/V/nystagmus
*Three clinical findings of MCA stroke
Contralateral motor (arms>leg)
Contralateral sensory defects
Expressive aphasia (L), dysarthria/neglect (R)
Agnosia
Ipsilateral hemianopsia
*Old man found next to his bed in nursing or retirement home. Seen normal two hours ago at dinner. R sided hemiparesis. Unable to speak. What are absolute and relative contraindications to tPA despite the patient being the in the window.
Absolute
Active ICH
Active other bleed
Pt refusal or not in GOC
Relative m
CVA in last 3 months
Spine surgery in last 3 months
Spine or head trauma last 3 months
Active AD
Active IE
Platelets <100
DOAC
*What are 5 signs of stroke on a non contrast CT?
Hyperdense artery sign (thrombus in vessel)
Sulcal effacement
Loss of the insular ribbon
Loss of grey-white interface
Mass effect
Acute hypodensity
*What are 5 causes for this patient’s presentation other than stroke?
Hypoglycemia
Seizure
Migraine
Hyponatremia
Encephalitis
Wernicke’s
Intoxication
*Hypertension and normal non-contrast CT head — R sided hemiparesis 230/125
1. Six things on the differential of this presentation with a normal CT head?
- Acute ischemic stroke (can still have a normal plain CT brain in this case)
- Migraine
- Todd’s paralysis
- Internal carotid artery dissection
- GCA
- Aortic dissection
- CVT
- Hypoglycemia
Think of it in two categories - things you need different CT for (carotid dissection, aortic dissection, CVT) and then mimics (hypoglycemia, Todd’s paralysis, complex migraine, GCA)
*6 reasons to decrease BP in this patient?
- If you’re going to thrombolyse them (ie, ischemic stroke inside the window)
- If they’re having an aortic dissection
- Reduce risk of intracranial hemorrhage
- Signs of raised ICP
- Acute myocardial infarction
- Hypertensive encephalopathy (10-15% reduction)
- Severe left ventricular heart failure
- Should slowly reduce BP over 24h even in ischemic stroke not getting tPA (15-25%)
*ACEP vs CAEP guidelines for tPA windows. ACEP says 4.5 hours, CAEP doesn’t recommend 3-4.5 hour tPA. 3 reasons why CAEP does not recommend 3-4.5 hours?
Question is now irrelevant - seems everyone is on board with 4.5h. (following Canada’s stroke best practice guidelines)
*tPA airway complication? One thing
Angioedema
*Most common location of hypertensive hemorrhagic stroke
Putamen (44%)
Thalamus (13%)
Cerebellum (9%)
Pons (9%)
Other cortical areas (25%)
PT for CP
*Patients ICP is 40. BP is now 120/60. Calculate CPP
CPP = MAP – ICP
MAP = 1/3 (SBP – DBP) + DBP.
CPP = 80 - 40 = 40 mmHg
*What is the range over which CPP is auto-regulated.
50-160
*5 signs of increased ICP on CT
- Compressed basal cisterns
- Diffuse sulcal effacement
- Diffuse loss of differentiation between gray and white matter
- Midline shift
- Compressed ventricle
- Brain herniation
*4 treatment in the ED (non-operative) for increased ICP
- Elevate head of bed
- Maintain neutral head and neck position to avoid jugular venous compression
- Mannitol
- Hypertonic saline
- Hyperventilate to PCO2 30-35 mmHg
- Sedation
- Analgesia
- Anti-emetics
- Treat fever
*Visual stim of pontine hemorrhage: three characteristic clinical findings of the lesion
decreased level of consciousness (most common)
long tract signs including tetraparesis
cranial nerve palsies
pinpoint pupils
seizures
Cheyne-Stokes respiration